Scientific, technical, and strategic solutions for Biomedical R&D
Because it takes a village
Because it takes a village
Why Taher?
Taher RD was established to harness decades of leadership in drug discovery, portfolio thinking, and experience across major pharmaceutical companies, venture-backed biotechs, and collaborative alliances. Leveraging a robust network of colleagues, Taher aspires to serve as a comprehensive expertise forum, providing tailored consulting services across all facets of drug discovery and development, regardless of therapeutic focus or modality. All ultimately to achieve the collective objective of delivering meaningful innovative medicines to patients.
Founded in 2025 by Ivan Cornella, PhD, Taher represents his commitment to fostering flexible international collaborations and partnerships, to share valuable insights in biomedical research while being respectful with intellectual property and diligent maintaining the necessary confidentiality firewalls.
Why now?
In the capital-intensive and selective biotech funding environment, founders and R&D leaders must adopt flexible enterprise management strategies integrating scientific ambition with financial discipline. Taher RD addresses this requirement by aligning drug discovery expertise with versatile operational models, supporting a range of entities—from academic teams and investors to biotech and pharmaceutical companies worldwide—in optimizing internal and external capabilities, prioritizing assets for value creation, and structuring partnerships and outsourcing arrangements to preserve resources while maintaining strategic flexibility.
Brookline, Massachusetts, USA